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ABSTRACT
Background: Healthcare-associated infections (HAIs) increase morbidity, mortality, length of hospital
stay and costs, and should be prevented where possible. In addition, up to 71% of neonates are prone
to bloodstream infections (BSI) during intensive care due to a variety of factors. Consequently, the
objectives of this study were to estimate the burden of HAIs and possible risk factors in a tertiary
hospital in Botswana as well as describe current trends in bacterial isolates from neonatal blood
specimen and their antibiotic resistance patterns.
Methods: Point Prevalence Survey (PPS) in all hospital wards and a retrospective cross-sectional review of
neonatal blood culture and sensitivity test results, with data abstracted from the hospital laboratory database.
Results: 13.54% (n = 47) of patients had HAIs, with 48.9% (n = 23) of them lab-confirmed. The highest
prevalence of HAIs was in the adult intensive care unit (100% – n = 5), the nephrology unit (50% – n = 4),
and the neonatal intensive care unit (41.9% – n = 13). One-fourth of HAIs were site unspecific, 19.1%
(n = 9) had surgical site infections (SSIs), 17% (n = 8) ventilator-associated pneumonia/complications, and
10.6% (n = 5) were decubitus ulcer infections. There were concerns with overcrowding in some wards and
the lack of aseptic practices and hygiene. These issues are now being addressed through a number of
initiatives. Coagulase Negative Staphylococci (CoNS) was the commonest organism (31.97%) isolated
followed by Enterococci spp. (18.03%) among neonates. Prescribing of third-generation cephalosporins
is being monitored to reduce Enterococci, Pseudomonas and Acinetobacter spp. infections.
Conclusions: There were concerns with the rate of HAIs and BSIs. A number of initiatives are now in place in
the hospital to reduce these including promoting improved infection prevention and control (IPC) practices
and use of antibiotics via focal persons of the multidisciplinary IPC committee. These will be followed up and
reported on.
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1. Introduction
Healthcare-associated infections (HAIs) refer to any systemic or
localized conditions that result from the reaction by an infec-
tious agent or toxin from a health-care setting [1]. HAIs are
increasingly seen as a global public health threat as they are
associated with increased morbidity and mortality, hospital
length of stay, as well as appreciably increased overall costs
[2–7]. HAIs have become more common as medical care has
become more complex with more complicated patients, which
has resulted in the increased use of invasive central line
catheters, urinary catheters and ventilators, predisposing
patients to potential HAIs [4,8,9].
Recent publications from the US suggest central line-
associated bloodstream infections are the most costly HAI at
$45,814 per case, followed by ventilator-associated pneumonia
at $40,144, and surgical site infections (SSIs) at $20,785 per case,
with catheter-associated urinary tract infections the least costly
at $896 per case [10]. Preventing 70% of HAIs in the US is
estimated to save from US$25billion to US$31.5billion per year
[8,10], with the current median length of stays in hospitals
approximately 2-fold higher in patients with HAIs compared
with those without [11]. National targets have recently been
introduced in the US to further lower HAI rates from approxi-
mately one in 25 hospital patients to lower [12,13]. In Europe, the
prevalence of HAIs varies from 4.8% in district (primary) hospitals
up to 7.2% in tertiary hospitals, with respiratory tract infections
(pneumonia – 19.4%, and other lower respiratory tract infections
– 4.1%), SSIs – 19.6%, urinary tract infections – 19.0%, and
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bloodstream infections – 10.7%, the most common [13,14]. HAIs
are appreciably more common in low and middle-income coun-
tries (LMICs) than higher-income countries averaging up to 8% to
15% or higher among hospital patients [4,7,13,15–17]. In LMICs,
the situation is compounded by a number of countries lacking
effective infection prevention and control (IPC) programs exacer-
bated by the lack of antibiotic policies, poor laboratory support,
limited resources, suboptimal adherence to safe practices and
typically limited compulsion to report HAIs [18–20].
These high rates of HAIs in LMICs are a concern with
a number of studies demonstrating the effectiveness of differ-
ent interventions to prevent HAIs [8,21–23]. This includes audit
and feedback, improving environmental hygiene, increasing
the use of antiseptic products, instigation of antimicrobial
stewardship programs (ASPs) as well as sterilization of devices
[8,24–27]. Surveillance of HAIs is also a critical component of
any future strategy to reduce HAIs within hospitals [7,28].
The prevalence of HAIs in Botswana hospitals is currently
unknown. Whilst some hospitals in Botswana have started
embarking on monitoring of HAIs due to the requirements of
the health-care accreditation process, this is currently not stan-
dardized. There are also concerns with the inadequacy of report-
ing. This is particularly important in Botswana given the high
prevalence of HIV among in-patients [29,30] that are immune-
compromised. Ways to address this include recognizing and
explaining HAIs; subsequently, implementing interventions to
decrease infection rates and limit antimicrobial resistance [31].
In addition, promoting effective infection control mechanisms
within a hospital including establishing an IPC team to co-
ordinate activities. Consequently, accurate quantification of cur-
rent HAI rates is needed to help justify any allocation of resources
dedicated to IPC teams and surveillance strategies. In view of
this, we sought to ascertain current rates of HAIs within a tertiary
hospital in Botswana to help develop pertinent strategies for this
hospital and later throughout Botswana to reduce HAIs if current
rates were found to be a concern.
Concomitant with this, we also sought to specifically assess
the current prevalence of neonatal bloodstream infections
(BSIs) and current antimicrobial resistance (AMR) rates within
the hospital to help target future intervention programs if BSIs
are a concern. This is also a priority area across countries with
up to ten million neonates worldwide dying within 5 days of
birth, and most of these in LMICs due to BSIs [32,33]. Overall,
up to 71% of neonates are prone to BSIs during intensive care,
with neonatal infections contributing substantially to the mor-
bidity and mortality of infants [34–36]. This is due to risk
factors such as low birth weight, gestational age, administra-
tion of parenteral nutrition as well as the use of invasive
devices and procedures [37]. Indiscriminate antibiotic use,
coupled with poor IPC practices, leads to high infection rates
and emergence of AMR [38]. However, screening for Group
B Streptococcus (GBS) among mothers can avoid early onset of
GBS among infants and help reduce mortality alongside con-
sidering intrapartum antibiotic prophylaxis [36,39,40].
Currently, the trends in the prevalence of neonatal BSI and
the current antibiotic sensitivities are unknown in this hospital
and wider to inform future IPC initiatives as well as any ASPs.
Consequently, this study aims to describe current trends in
bacterial isolates from neonatal blood specimens as well as
their antibiotic resistance patterns, and subsequently estimate
the burden of HAIs and possible risk factors in the hospital.
2. Methodology
The study consisted of two parts and the study site chosen
was Nyangabgwe Hospital, a tertiary hospital in northern
Botswana with a total bed capacity of 572. The first part
used a Point Prevalence Survey (PPS) design to ascertain the
prevalence of HAIs in the hospital and possible risk factors
based on previous publications. The second part involved
a retrospective cross-sectional review of blood culture and
sensitivity results of neonates.
2.1 PPS to ascertain current HAI rates
In the first part, the PPS was performed on a single day across the
entire 15 admitting wards of the hospital in November 2017. This
method was chosen due to the unavailability of previous hospi-
tal-wide surveillance data for IPC activities. Fifteen admitting
wards with 510 beds were included in the survey. We excluded
the psychiatric wards as they do not admit patients with infec-
tious conditions and the labor ward as they admit only women
who are in active phase of labor and are discharged thereafter to
the post-natal ward. Medical records of all admitted patients on
the day of the survey were reviewed. HAIs were defined as
infections that were not present or incubating during the time
of admission to the hospital. Cases were identified as those that
became pyrexial 48 h after admission and assessed using CDC-
definitions, similar to other studies [7,14,17,41,42].
Data collection was undertaken by a trained multidisciplin-
ary IPC team, which included a clinical microbiologist, using
a structured data collection tool that incorporated the CDC
case definitions for accurate identification of HAI cases and
possible risk factors. A pilot survey was conducted in the
previous year and the structured data collection tool was
revised as required to enhance accuracy in identifying cases.
Data were analyzed using MS-Excel 2013 and the results of
categorical variables including possible risk factors were pre-
sented as percentages. No attempt was made to calculate
odds ratios or relative risk in view of the nature of the study
design as the study was undertaken to improve local quality of
care. The findings of the study were first discussed in the
hospital IPC committee with the study abstract approved by
Health Research and Development Division at the Ministry of
Health and Wellness Botswana (HPDME-13/18/1) before sub-
mission for potential publication.
2.2 Neonatal basis
The second part involved a retrospective cross-sectional
review of neonatal blood culture and sensitivity test results
that was undertaken from January 2014 to December 2017.
The study setting was a 28 bedded special care baby unit
(SCBU) with six neonatal intensive care beds with an annual
bed occupancy rate of 80% to 85%. Neonates were defined as
babies aged less than 28 days irrespective of their gestational
age based on patients’ notes and BSIs were pathogenic bac-
teria isolated from blood cultures drawn from neonates
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admitted in SCBU. Whilst considered as a contaminant as per
laboratory procedures, Coagulase Negative Staphylococci
(CoNS) is treated as pathogenic if the same isolation is
observed in two simultaneous blood cultures from two differ-
ent sites correlating with the clinical signs and symptoms for
infection. This differentiation is observed as a collaborative
diagnosis made by the treating clinician in consultation with
the microbiologist during the provision of care and documen-
ted as such in patient medical records [43].
Data were collected from the hospital microbiology lab
database; the hospital laboratory was accredited by the
Southern African Development Community Accreditation
Services (SADCAS). The results were sorted for the tested
positive blood specimens and analyzed using MS-Excel 2013.
The prevalence of isolated bacteria and their resistance to
antibiotics were presented in percentages. The findings of
this part of the study were also discussed in the Hospital IPC
committee. The abstract was approved by the Health Research
and Development Division at Ministry of Health and Wellness
(MoHW) Botswana (HPDME-13/18/1) before submission for
publication.
3. Results
3.1 PPS for HAIs
The bed occupancy rate on the date of the survey was 68%
(n = 347). Overall, more than 1 out of 10 patients (13.54%,
n = 47) were identified as having a HAI. Of the identified cases,
48.9% (n = 23) were laboratory confirmed. The prevalence of
HAIs was highest in the adult intensive care unit (100% –
n = 5), the nephrology unit (50% – n = 4), the special care
baby unit (41.9% – n = 13), and the paediatric medical ward
(33.3% – n = 8) (Table 1).
In terms of the sites of infections, approximately one-fourth of
the HAIs were site unspecific and mostly observed in neonates.
The highest prevalence of HAIs was observed from surgical sites
including post-surgical osteomyelitis and intracranial infections
(23.4% – n = 11) followed by ventilator-associated conditions/
infections (17% – n = 8 from 126 mechanical ventilation days),
decubitus ulcers (10.6% – n = 5), laboratory-confirmed blood-
stream infections (8.5% – n = 4) and urinary tract infections
(6.4% – n = 3) (Table 2).
Regarding the possible risk factors for HAIs, 51% (n = 178)
of patients had received antibiotics of which 79.2% (n = 141)
received injectable antibiotics and 32.5% (n = 58) had received
more than 2 antibiotics. Forty-eight percent (n = 166) of
patients had an intravenous catheter, and 24% of patients
received an invasive procedure that required an incision in
the body. The risk of acquiring a ventilator-associated infec-
tion is 0.06 per mechanical ventilation day. Other risk factors
are shown in Table 3.
3.2 Neonatal BSI study
Of the total 366 isolates, 56.01% were from male neonates.
62.3% of blood cultures were ordered within the first week of
life. Coagulase Negative Staphylococci (CoNS) was the com-
monest organism (31.97%) isolated followed by Enterococci
spp. (18.03%). Other bacteria and their prevalence are con-
tained in Box 1.
The trends in the prevalence of bacterial pathogens caus-
ing bloodstream infections showed a mixed pattern of
increases and decreases over the period of the study (Figure
1). The highest prevalence was observed with CoNS, which
after a significant drop in 2014 steadily increased thereafter.
This is followed by Enterococci spp. showing a high prevalence,
but with a decline after 2016. As in most other settings,
ESKAPE (Enterococcus faecium, Staphylococcus aureus,
Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas
aeruginosa, and Enterobacter species) organisms are the most
common pathogens isolated. Whilst there was a decline of
Klebsiella pneumoniae from 2014, this changed in 2016 with
a steady increase thereafter. This was similar to the situation
seen with Staphylococcus aureus. On the other hand, the pre-
valence of E. coli remained high between 2014 and 2016;
however, declining after that. There was a low prevalence of
Pseudomonas aeruginosa throughout the study, and
Acinetobacter spp showed moderate fluctuations (Figure 1).
Regarding the prevalence of drug-resistant pathogens in
2017, extended spectrum beta-lactamase (ESBL) producing
Klebsiella pneumoniae, Enterobacter spp. and E. coli were at
55%, 15.38%, and 11.11%, respectively. K. pneumoniae and E.
coli showed an increasing trend in ESBL producing strains
although no KPC (Klebsiella pneumoniae carbapenemase)
Table 1. Prevalence of HAIs in different wards.
Ward Admissions Bed capacity Bed occupancy (%) HAI cases HAI cases (%)
Adult Intensive Care 5 6 83.3 5 100.0
Private (Housing Nephrology patients) 8 20 40.0 4 50.0
Special Care Baby Unit with Neonatal ICU 31 40 77.5 13 41.9
Paediatric Medical 24 40 60.0 8 33.3
Female Medical 29 50 58.0 3 10.3
Male Medical 39 50 78.0 4 10.3
Gynaecology II 13 15 86.7 1 7.7
Male Surgical 61 50 122.0 4 6.6
Post Natal 54 50 108.0 3 5.6
Gynaecology I 21 35 60.0 1 4.8
Female Surgical 27 50 54.0 1 3.7
Ante Natal 13 30 43.3 0 0
Isolation 6 24 25.0 0 0
Paediatric Surgical 15 30 50.0 0 0
TB 1 20 5.0 0 0
Overall 347 510 68.0 47 13.54
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strains were identified. Of the S. aureus isolates, 19.35% were
methicillin resistant (MRSA) while 6.06% of Enterococcus spp.
were resistant to vancomycin (VRE) and were isolated only in
2017. Acinetobacter spp. showed 100% resistance to merope-
nem, cephalosporins, aminoglycosides, and fluoroquinolones.
Candida spp. contributed 3.28% to positive isolates.
4. Discussion
The overall point prevalence of HAIs in this hospital was 13.5%,
which is similar or lower than other LMICs [4,13,15–17,44]. Not
surprisingly, a higher prevalence of HAIs occurred in the inten-
sive care and dialysis units (Table 1) consistent with other studies
[15,44–47]. The majority of the patients admitted to the ICU and
neonatal ICU had undergone invasive procedures, had more
complicated conditions with a long period of hospitalization
and had long-term use of antibiotics predisposing them to the
risk of acquiringmultidrug-resistant infections. In neonates, gross
prematurity and related immature immunity remain a risk factor
for acquiring infections [48,49]. Risk factors that predispose to
respiratory infections include the use of a ventilator, intubation,
incision, non-standardized performance of sputum aspiration,
improper oral care, as well as a poor ward environment [50].
HAIs were principally found in surgical incision sites, the
respiratory tract and decubitus ulcers (Table 2), again similar to
other studies [45,46]. Even though different studies have
reported different sites of infection, the respiratory tract, surgical
incision sites, and urinary tracts are among the most commonly
reported sites for HAIs in published studies [13,18,45,46].
During this study, it was observed thatmale surgical and post-
natal wards were overcrowded with floor beds due to bed
occupancy rates above 100% (Table 1). The patient to nurse
ratio was also a concern in a number of units including the
special care baby unit (SCBU) with ratios typically around one
nurse to each neonate in NICU [51,52], with every extra patient
added to the workload known to increase the chances of
patients being re-admitted, prolonging hospital stays or dying
[52,53]. In addition, whilst preoperative bathing is recommended
by the WHO and others, this is not currently being routinely
practiced in this hospital exacerbated by the lack of nurses and
overcrowding in some wards [54,55]. On the other hand, whilst
the use of razors for removal of hair at the surgical sites has been
shown to increase the rate of surgical site infections (SSIs) in
some studies, with no scientific basis in others [55–58], this is still
observed in our hospital potentially increasing the risk of SSIs.
Shortages of sterile dressing packs and drapes due to
occasional downtime of boilers and autoclaves, as well as
the lack of laundry equipment and alcohol hand rubs by
patients’ bedsides, may also have contributed to the quality
of dressings during post-surgical care and managing decubi-
tus ulcers thereby increasing HAI rates. Theatre temperatures
were also observed to be elevated at times due to malfunc-
tioning chillers and air-conditioners during surgery, further
adding to potential HAIs. Shortages of single-use tracheal
suctioning catheters also occurred in the hospital during the
study, which resulted at times in the reuse of disinfected
catheters in the same patients, which could also potentially
increase the risks of HAIs. In addition, whilst studies have not
shown significant differences between closed and openTa
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tracheal suctioning systems, the hospital currently uses an
open suctioning system which combined with poor IPC prac-
tices may increase ventilator-associated infections. Closed tra-
cheal suctioning systems are helpful in limiting environmental,
personal and patient contamination [59]. In addition, at times
there were few operational mechanical ventilators;
consequently, routine sterilization could be a problem adding
to potential HAIs.
In view of the findings, there have been a number of
initiatives put in place in the hospital in line with CDC recom-
mendations [60]. These include routinely undertaking assess-
ments to help ensure appropriate hand hygiene, cleaning and
disinfection practices, adherence to isolation procedures,
aseptic techniques, visiting procedures, proper wound and
device care and ensuring commodity availability as part of
IPC quality improvement activities. A series of measures for
training, education, and evaluations are currently being imple-
mented in the hospital to improve the awareness of ways to
minimize HAI risks. Placement of posters as reminders for
hand washing and precautions are also now placed in strate-
gic locations in the hospital. Publication of a hospital IPC
newsletter was also initiated. These measures are expected
to reduce the risk of HAIs effectively [50,54]. Heads of depart-
ments, departmental focal persons and administrative staff
have also been involved with measures to increase compli-
ance to hand hygiene and for appropriate handling and
Table 3. Risk Factors for HAIs.
Risk Factors ANW FMW FSW GYNAE I GYNAE II ICU ISO MMW MSW PMW PNW PSW PVT SCBU TB Total %
No. of patients on antibiotics 1 16 11 14 5 5 6 15 36 17 18 9 6 18 1 178 51
No. of patients on injectable antibiotics 1 15 10 7 4 5 3 12 27 12 14 7 5 18 1 141 41
No. of patients with more than 2
antibiotics
0 3 4 5 1 1 5 2 13 5 2 3 2 12 0 58 17
No. of patients on urinary catheter 0 3 4 3 2 5 0 6 4 0 6 0 2 0 0 35 10
No. of patients on intravenous cannula 3 11 14 15 6 1 3 27 27 13 14 9 8 14 1 166 48
No. of patient on central venous catheter 0 1 0 0 0 4 0 0 0 0 0 0 0 0 0 5 1
No. of patients on other type of catheters 0 3 0 0 0 0 0 3 0 0 0 0 0 3 0 9 3
No. of patients received an invasive
procedure
0 2 6 4 6 5 0 4 18 2 12 4 7 13 0 83 24
No. of patients previously hospitalized in
90 days
0 1 1 4 0 0 0 0 12 10 0 4 0 0 0 32 9
No. of patients on mechanical ventilators 0 0 0 0 0 3 0 0 0 1 0 0 0 5 0 10 3
No of days on mechanical ventilator 0 0 0 0 0 68 0 0 0 2 0 0 0 56 0 126
No. of patients on mechanical devices 0 1 0 2 0 0 0 0 9 1 0 0 0 0 0 13 4
No of days on mechanical devices 0 41 0 0 0 0 0 0 0 2 0 0 0 0 0 43
Total admissions 13 29 27 21 13 5 6 39 61 24 54 15 8 31 1 347 100
NB: SCBU-Special Baby Care Unit with Neonatal ICU; PMW-Paediatric Medical Ward; ICU-Adult Intensive Care; MMW-Male Medical Ward; MSW-Male Surgical Ward;
PVT-Private Ward; FMW-Female Medical Ward; PNW-Post Natal Ward; FSW-Female Surgical Ward; GYN I-Gynaecology Ward 1; GYN II – Gynaecology Ward 2; ANW-
Ante Natal Ward; ISO-Isolation; PSW-Paediatric Surgical Ward; TB-Tuberculosis Ward.
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Figure 1. Trends in the prevalence of bacteria causing neonatal BSI.
Box 1. Prevalence of bacteria causing neonatal BSI.
● Coagulase Negative Staphylococci (CoNS) – 31.97%
● Enterococci spp. – 18.03%
● Klebsiella pneumoniae – 10.93%
● Staphylococcus aureus – 8.47%
● Escherichia coli – 7.38%
● Acinetobacter spp. – 4.64%
● Enterobacter spp. – 3.55%
● Group-B Streptococci – 2.46%
● Streptococci viridans – 2.19%
● Pseudomonas aeruginosa – 1.09%
HOSPITAL PRACTICE 5
disposal of healthcare waste. The objectives of IPC have also
been integrated into departmental annual performance plans
and individual performance objectives to promote staff own-
ership of these measures to reduce HAI rates in the hospital,
and this is being monitored.
Blood is the commonest specimen drawn from neonates for
culture with two-thirds drawn within the first 7 days of life. As
with other studies in premature neonates [43,61], CoNS were the
predominantly isolated bacteria. Skin antisepsis prior to blood
specimen collection is also emphasized to nursing staff to pre-
vent specimen contamination. ESKAPE organisms, E. coli and
Streptococci spp. were the most isolated pathogens, again similar
to a number of other studies [32,33,36,61–63]. Recently the pro-
tocol for the treatment of neonatal infections were reviewed to
reduce the use of third-generation cephalosporins to help
reduce Enterococci, and Acinetobacter spp. infections, and this is
being followed up. Efforts are also in place to prevent shortages
of antibiotics and patients missing antibiotic doses, which has
been a concern in point prevalence studies in Botswana [29,64].
These efforts are expected to reduce the emergence and spread
of infections at the neonatal unit complemented by implemen-
ted IPC initiatives.
We are aware of a number of limitations with these studies.
Firstly, the PPS survey involved a review of medical records of
patients and therefore only patients with documented urinary
tract infections had the possibility of inclusion and asymptomatic
patients might have been left out. Moreover, urinary specimens
were not collected from all patients who remained on a urinary
catheter during the survey for active case finding. In this study
again, no attempt was made to calculate odds ratios or relative
risk in view of the nature of the study design. In addition, the
study was only undertaken in one hospital. Never-the-less, we
believe our findings are robust considering this was the second
largest public hospital with also a neonatal setting, thus provid-
ing suitable direction to stimulate IPC activities in this and other
hospitals in Botswana.
5. Conclusion
In conclusion, we found that more than 1 in 10 patients acquired
infections during their stay in the hospital. Prioritized efforts are
needed in adult intensive care unit, nephrology, neonatology, and
pediatric wards to improve practices as there is a higher risk of
patients acquiring HAIs in these wards due to the frequent use of
invasive devices. Decongesting post-natal and surgical wards,
strengthening nurse-patient ratios, and taking preventative mea-
sures to reduce surgical site infections, are critical to reducing the
prevalence of HAIs in the future. Currently, approximately 50% of
patients in the hospital received antibiotics and persistent efforts
are essential to improve antibiotic use to further reduce the emer-
gence of drug-resistant strains of bacteria including Enterococci
and ESBL producing strains of Klebsiella among ESKAPE organisms.
The ongoing initiatives are being monitored, and the findings will
be used to develop additional programs if needed to reduce the
rates of HAIs and BSIs in this hospital and wider in Botswana.
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